The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antibody Fusion Protein Market Research Report 2024
Synopsis
Antibody fusion protein refers to the recombinant protein that connects the target gene with the fragment gene of immunoglobulin at the gene level, downloads it and expresses it in a eukaryotic or prokaryotic expression system.
Global Antibody Fusion Protein market is projected to reach US$ 66380 million in 2029, increasing from US$ 32780 million in 2022, with the CAGR of 10.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antibody Fusion Protein market research.
The antibody fusion protein market is driven by its potential to revolutionize targeted therapies and address unmet medical needs. These fusion proteins combine the specificity of antibodies with the therapeutic effects of other molecules, offering novel treatment options for various diseases, including cancer, autoimmune disorders, and infectious diseases. The ability to precisely target specific cells or molecules enhances efficacy while potentially reducing side effects. Moreover, advancements in biotechnology and genetic engineering have enabled the development of more potent and personalized antibody fusion proteins. However, the market faces challenges such as complex manufacturing processes, high development costs, and regulatory hurdles for approval. Overcoming these challenges and continued research in this field will be crucial for maximizing the therapeutic potential and driving the growth of the antibody fusion protein market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antibody Fusion Protein market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
Bristol-Myers Squibb
Regeneron
Bayer
Amgen
Pfizer
Eli Lilly and Company
Sobi
Kanghong Pharma
3SBIO
Celgen Biopharma
Segment by Type
Brands Drugs
Biosimilar Drugs
Segment by Application
Autoimmune Disease
Eye Diseases
Diabetes
Hemophilia
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Antibody Fusion Protein report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Antibody fusion protein refers to the recombinant protein that connects the target gene with the fragment gene of immunoglobulin at the gene level, downloads it and expresses it in a eukaryotic or prokaryotic expression system.
Global Antibody Fusion Protein market is projected to reach US$ 66380 million in 2029, increasing from US$ 32780 million in 2022, with the CAGR of 10.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antibody Fusion Protein market research.
The antibody fusion protein market is driven by its potential to revolutionize targeted therapies and address unmet medical needs. These fusion proteins combine the specificity of antibodies with the therapeutic effects of other molecules, offering novel treatment options for various diseases, including cancer, autoimmune disorders, and infectious diseases. The ability to precisely target specific cells or molecules enhances efficacy while potentially reducing side effects. Moreover, advancements in biotechnology and genetic engineering have enabled the development of more potent and personalized antibody fusion proteins. However, the market faces challenges such as complex manufacturing processes, high development costs, and regulatory hurdles for approval. Overcoming these challenges and continued research in this field will be crucial for maximizing the therapeutic potential and driving the growth of the antibody fusion protein market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antibody Fusion Protein market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
Bristol-Myers Squibb
Regeneron
Bayer
Amgen
Pfizer
Eli Lilly and Company
Sobi
Kanghong Pharma
3SBIO
Celgen Biopharma
Segment by Type
Brands Drugs
Biosimilar Drugs
Segment by Application
Autoimmune Disease
Eye Diseases
Diabetes
Hemophilia
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Antibody Fusion Protein report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Fusion Protein Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Brands Drugs
1.2.3 Biosimilar Drugs
1.3 Market by Application
1.3.1 Global Antibody Fusion Protein Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Autoimmune Disease
1.3.3 Eye Diseases
1.3.4 Diabetes
1.3.5 Hemophilia
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Fusion Protein Market Perspective (2018-2029)
2.2 Antibody Fusion Protein Growth Trends by Region
2.2.1 Global Antibody Fusion Protein Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antibody Fusion Protein Historic Market Size by Region (2018-2023)
2.2.3 Antibody Fusion Protein Forecasted Market Size by Region (2024-2029)
2.3 Antibody Fusion Protein Market Dynamics
2.3.1 Antibody Fusion Protein Industry Trends
2.3.2 Antibody Fusion Protein Market Drivers
2.3.3 Antibody Fusion Protein Market Challenges
2.3.4 Antibody Fusion Protein Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Fusion Protein Players by Revenue
3.1.1 Global Top Antibody Fusion Protein Players by Revenue (2018-2023)
3.1.2 Global Antibody Fusion Protein Revenue Market Share by Players (2018-2023)
3.2 Global Antibody Fusion Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Fusion Protein Revenue
3.4 Global Antibody Fusion Protein Market Concentration Ratio
3.4.1 Global Antibody Fusion Protein Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Fusion Protein Revenue in 2022
3.5 Antibody Fusion Protein Key Players Head office and Area Served
3.6 Key Players Antibody Fusion Protein Product Solution and Service
3.7 Date of Enter into Antibody Fusion Protein Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Fusion Protein Breakdown Data by Type
4.1 Global Antibody Fusion Protein Historic Market Size by Type (2018-2023)
4.2 Global Antibody Fusion Protein Forecasted Market Size by Type (2024-2029)
5 Antibody Fusion Protein Breakdown Data by Application
5.1 Global Antibody Fusion Protein Historic Market Size by Application (2018-2023)
5.2 Global Antibody Fusion Protein Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Antibody Fusion Protein Market Size (2018-2029)
6.2 North America Antibody Fusion Protein Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Antibody Fusion Protein Market Size by Country (2018-2023)
6.4 North America Antibody Fusion Protein Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Fusion Protein Market Size (2018-2029)
7.2 Europe Antibody Fusion Protein Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Antibody Fusion Protein Market Size by Country (2018-2023)
7.4 Europe Antibody Fusion Protein Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Fusion Protein Market Size (2018-2029)
8.2 Asia-Pacific Antibody Fusion Protein Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Antibody Fusion Protein Market Size by Region (2018-2023)
8.4 Asia-Pacific Antibody Fusion Protein Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Fusion Protein Market Size (2018-2029)
9.2 Latin America Antibody Fusion Protein Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Antibody Fusion Protein Market Size by Country (2018-2023)
9.4 Latin America Antibody Fusion Protein Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Fusion Protein Market Size (2018-2029)
10.2 Middle East & Africa Antibody Fusion Protein Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Antibody Fusion Protein Market Size by Country (2018-2023)
10.4 Middle East & Africa Antibody Fusion Protein Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Antibody Fusion Protein Introduction
11.1.4 Sanofi Revenue in Antibody Fusion Protein Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Antibody Fusion Protein Introduction
11.2.4 Bristol-Myers Squibb Revenue in Antibody Fusion Protein Business (2018-2023)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Regeneron
11.3.1 Regeneron Company Detail
11.3.2 Regeneron Business Overview
11.3.3 Regeneron Antibody Fusion Protein Introduction
11.3.4 Regeneron Revenue in Antibody Fusion Protein Business (2018-2023)
11.3.5 Regeneron Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Antibody Fusion Protein Introduction
11.4.4 Bayer Revenue in Antibody Fusion Protein Business (2018-2023)
11.4.5 Bayer Recent Development
11.5 Amgen
11.5.1 Amgen Company Detail
11.5.2 Amgen Business Overview
11.5.3 Amgen Antibody Fusion Protein Introduction
11.5.4 Amgen Revenue in Antibody Fusion Protein Business (2018-2023)
11.5.5 Amgen Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Antibody Fusion Protein Introduction
11.6.4 Pfizer Revenue in Antibody Fusion Protein Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Detail
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Antibody Fusion Protein Introduction
11.7.4 Eli Lilly and Company Revenue in Antibody Fusion Protein Business (2018-2023)
11.7.5 Eli Lilly and Company Recent Development
11.8 Sobi
11.8.1 Sobi Company Detail
11.8.2 Sobi Business Overview
11.8.3 Sobi Antibody Fusion Protein Introduction
11.8.4 Sobi Revenue in Antibody Fusion Protein Business (2018-2023)
11.8.5 Sobi Recent Development
11.9 Kanghong Pharma
11.9.1 Kanghong Pharma Company Detail
11.9.2 Kanghong Pharma Business Overview
11.9.3 Kanghong Pharma Antibody Fusion Protein Introduction
11.9.4 Kanghong Pharma Revenue in Antibody Fusion Protein Business (2018-2023)
11.9.5 Kanghong Pharma Recent Development
11.10 3SBIO
11.10.1 3SBIO Company Detail
11.10.2 3SBIO Business Overview
11.10.3 3SBIO Antibody Fusion Protein Introduction
11.10.4 3SBIO Revenue in Antibody Fusion Protein Business (2018-2023)
11.10.5 3SBIO Recent Development
11.11 Celgen Biopharma
11.11.1 Celgen Biopharma Company Detail
11.11.2 Celgen Biopharma Business Overview
11.11.3 Celgen Biopharma Antibody Fusion Protein Introduction
11.11.4 Celgen Biopharma Revenue in Antibody Fusion Protein Business (2018-2023)
11.11.5 Celgen Biopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
